Scientific Sessions 2024  /  Annual Lipid Updates - 2024  /  The Role of Advanced Lipid Testing in 2024
Logo

American Heart Association

  9
  0

Final ID:

The Role of Advanced Lipid Testing in 2024

  • Shapiro, Michael  ( Wake Forest Univ School of Medicine , Winston Salem , North Carolina , United States )
  • Gianos, Eugenia  ( Lenox Hill- Northwell Health , New York , New York , United States )
  • Taub, Pam  ( UCSD MEDICAL CENTER , La Jolla , California , United States )
  • Wilkinson, Michael  ( University of California San Diego , La Jolla , California , United States )
    • Author Disclosures:
    Michael Shapiro: DO have relevant financial relationships ; Consultant:Amgen:Active (exists now) ; Advisor:Arrowhead:Active (exists now) ; Advisor:Merck:Active (exists now) ; Consultant:Regeneron:Active (exists now) ; Advisor:Ionis:Active (exists now) ; Advisor:Agepha:Past (completed) ; Consultant:Novartis:Active (exists now) | Eugenia Gianos: DO have relevant financial relationships ; Speaker:Kaneka:Past (completed) ; Speaker:Medaxiom:Past (completed) | Pam Taub: DO have relevant financial relationships ; Consultant:Amgen:Active (exists now) ; Consultant:Boehringer Ingelheim/Lilly:Active (exists now) ; Consultant:Sanofi:Active (exists now) ; Consultant:Medtronic:Active (exists now) ; Consultant:Edwards:Active (exists now) ; Consultant:Esperion:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) ; Consultant:Novartis:Active (exists now) | Michael Wilkinson: DO have relevant financial relationships ; Consultant:Amarin:Active (exists now) ; Other (please indicate in the box next to the company name):Novartis - Writing and editing support provided by a third-party company for two manuscripts:Past (completed) ; Research Funding (PI or named investigator):Lilly - contracted research grants to his institution:Active (exists now) ; Research Funding (PI or named investigator):Mineralys - contracted research grants to his institution:Active (exists now) ; Research Funding (PI or named investigator):Ionis - contracted research grant to his institution:Active (exists now) ; Research Funding (PI or named investigator):Novartis - contracted research grants to his institution:Active (exists now) ; Research Funding (PI or named investigator):Amgen - contracted research grant to his institution:Active (exists now) ; Other (please indicate in the box next to the company name):Novartis - institutional consulting agreement with Novartis paid to his institution for advising on research:Active (exists now) ; Research Funding (PI or named investigator):Amgen:Past (completed) ; Speaker:Regeneron:Active (exists now) ; Advisor:NewAmsterdam:Active (exists now) ; Advisor:Novartis:Past (completed) ; Consultant:The Kinetix Group:Past (completed) ; Consultant:Kaneka:Active (exists now) ; Consultant:Regeneron:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Annual Lipid Updates - 2024

Sunday, 11/17/2024 , 08:00AM - 09:15AM

Cardiovascular Seminar

More abstracts on this topic:
Lipoprotein(a): Modifiable Risk Factor, Update in Targeted Therapies

Yeang Calvin, Bhatia Harpreet, Mehta Anurag

New Frontiers in Triglyceride Lowering

Tokgozoglu Lale, Remaley Alan T, Cariou Bertrand, Hudgins Lisa

More abstracts from these authors:
Circulating Ketone Bodies, Lipoprotein(a) and Incident Cardiovascular Outcomes and Mortality: Insights from The UK Biobank

Chevli Parag, Mirzai Saeid, Kazibwe Richard, Rikhi Rishi, Bhatia Harpreet, Slipczuk Leandro, Gianos Eugenia, Pagidipati Neha, Shapiro Michael

Panelist - Prevention

Taub Pam

You have to be authorized to contact abstract author. Please, Login
Not Available